Delivery Order SPE2DB24D2003-SPE2DB24FXCV3
- Not listed
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $23,003.57, was made to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The contract has an ultimate completion date of August 9, 2023 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order valued at $13,572.92 for the pharmaceutical product Rinvoq ER 15 mg Tablet. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC serves...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,491.18, is a firm fixed-price delivery order that does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which does business as...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $13,155.21 and a period of performance through January 29, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation indicated. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award is for the delivery of a specific pharmaceutical product, Rinvoq ER 15 mg tablets, to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order contract. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $11,585.33 and a completion date of September 1, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Rinvoq ER 15 mg tablets. The $41,370.53 firm fixed price delivery order is not associated with a set-aside program. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of...
- This contract award is for the delivery of Rinvoq ER 45 mg tablets to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $7,986.69 and a period of performance through February 8, 2024. This is a delivery order contract with a firm fixed price pricing type. The contract was not set aside for any specific business category. Amerisourcebergen Drug...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,370.89 firm fixed price delivery order is for RINVOQ ER 15 MG TABLET UU 30S, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
- This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a firm fixed price of $7,593.71 and an ultimate completion date of December 20, 2023. The contract is a delivery order, which is a type of indefinite delivery contract vehicle. This contract is not designated as a...
- This federal contract award, valued at $3,125.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Rinvoq ER 15 mg tablets, a medication used to treat certain medical conditions. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. The award is not associated with a set-aside program, indicating open...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB24FXCV3Delivery Order
This federal contract award is for the delivery of Rinvoq ER 15 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $34,531.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense globally. The contract has no set-aside designation, indicating open competition. This award demonstrates Amerisourcebergen's role as a critical supplier of essential medications and medical commodities to support military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.5k | 2/26/24 |